Seongyeol Park, MD, PhD, CRI Immuno-Informatics Fellow Stanford University Area of Research: Cáncer de mama Seongyeol Park, MD, PhD, a biomedical scientist trained in both medical and bioinformatics techniques, is tackling the challenges of triple-negative breast cancer (TNBC) treatment. His project at the Stanford Cancer Institute leverages advanced spatial omics to explore how TNBC tumors interact with metastatic organs and respond to immune checkpoint inhibitors (ICIs). By analyzing a unique set of clinical trial specimens, Dr. Park aims to create predictive models of ICI response, which could revolutionize treatment decisions for TNBC and other metastatic cancers. Having previously worked as an internal medicine doctor and cancer researcher, Dr. Park’s PhD in cancer genomics honed his expertise in computational oncology. His work on detecting complex cancer rearrangements and building phylogenetic models has been published in Cell and Nature, contributing significantly to our understanding of cancer evolution. «I’m focused on understanding how tumors evolve in different organs and how this affects their response to immunotherapy,» says Dr. Park. His work promises to improve cancer treatment strategies, ultimately guiding more effective and personalized approaches for metastatic cancer patients. Projects and Grants Organ-specific Cancer-Immune Co-evolution in Metastatic Breast Cancer Stanford University | Breast Cancer | 2025 | Christina Curtis, PhD, and Edgar Engleman, MD
